Anti-hepatitis B virus agent
View Patent ↗An anti-hepatitis B virus agent comprising a compound represented by general formula [1], wherein R 1 represents an aryl group, which may be substituted, or the like; R 2 represents an aryl group, which may be substituted, or the like; and R 3 represents a hydrogen atom or the like; or a salt thereof.
1. A method of treating hepatitis B virus, the method comprising administering an anti-hepatitis B virus agent to a patient in need thereof, the anti-hepatitis B virus agent comprising a compound represented by general formula [1]:
wherein R 1 represents an aryl group which may be substituted or a heterocyclic group which may be substituted;
R 2 represents a C 3-8 cycloalkyl group which may be substituted, an aryl group which may be substituted, or a heterocyclic group which may be substituted; and
R 3 represents a hydrogen atom or a carboxyl protecting group, or a salt thereof.
2. The method according to claim 1 , wherein R 1 represents an aryl group which may be substituted.
3. The method according to claim 1 , wherein R 1 represents a phenyl group which may be substituted.
4. The method according to claim 1 , wherein R 1 represents a heterocyclic group which may be substituted.
5. The method according to claim 1 , wherein R 1 represents a bicyclic heterocyclic group which may be substituted.
6. The method according to claim 1 , wherein R 2 represents an aryl group which may be substituted.
7. The method according to claim 1 , wherein R 2 represents a phenyl group which may be substituted.
8. The method according to claim 1 , wherein R 2 represents a heterocyclic group which may be substituted.
9. The method according to claim 1 , wherein R 2 represents a monocyclic heterocyclic group which may be substituted.